Molecular basis of IgA nephropathy

被引:14
作者
Lai, ASH [1 ]
Lai, KN [1 ]
机构
[1] Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China
关键词
IgA nephropathy; IgA; mesangial inflammation; tubulointerstitial injury; electrostatic charge; growth factors; renin-angiotensin system; angiotensin II receptors;
D O I
10.2174/1566524054553450
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
IgA nephropathy (IgAN) is the most common glomerulonephritis worldwide and remains an important cause of end-stage renal failure. However, the basic molecular mechanism(s) underlying abnormal IgA synthesis, selective mesangial deposition with ensuing mesangial cell proliferation and extracellular matrix expansion remains poorly understood. Notably, the severity of tubulointerstitial lesions better predicts the renal progression than the degree of glomerular lesions. The task of elucidating the molecular basis of IgAN is made especially challenging by the fact that both environmental and genetic components likely contribute to the development and progression of IgAN. This review will summarize the earlier works on the structure of the IgA molecule, mechanisms of mesangial IgA deposition and pathophysiologic effects of IgA on mesangial cells following mesangial deposition. Recently, a series of important advances in the area of communication between the glomerular mesangium and renal tubular cells have emerged. These novel findings regarding the molecular pathogenesis of IgAN will be helpful in designing future directions for therapy.
引用
收藏
页码:475 / 487
页数:13
相关论文
共 50 条
  • [31] LncRNAs and IgA nephropathy: underlying molecular pathways and clinical applications
    Mina Alimohammadi
    Samaneh Kahkesh
    Amirhosein Abbasi
    Mehrdad Hashemi
    Seyedeh Mahdieh Khoshnazar
    Afshin Taheriazam
    Kiavash Hushmandi
    Clinical and Experimental Medicine, 25 (1)
  • [32] IgA NEPHROPATHY AND RENAL CELL CARCINOMA: MOLECULAR GENETIC ANALYSIS
    Li, H. N.
    Chen, H.
    Yang, X. X.
    Xu, Y. Y.
    Cao, Y.
    Geng, J. S.
    Jin, X. M.
    Meng, H. X.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2019, 33 (05) : 1571 - 1575
  • [33] Mechanisms of tubulointerstitial injury in IgA nephropathy
    Lai, KN
    Chan, LYY
    Leung, JCK
    KIDNEY INTERNATIONAL, 2005, 67 : S110 - S115
  • [34] An update on the pathogenesis and treatment of IgA nephropathy
    Boyd, Joanna K.
    Cheung, Chee K.
    Molyneux, Karen
    Feehally, John
    Barratt, Jonathan
    KIDNEY INTERNATIONAL, 2012, 81 (09) : 833 - 843
  • [35] History of IgA Nephropathy Mouse Models
    Wehbi, Batoul
    Pascal, Virginie
    Zawil, Lina
    Cogne, Michel
    Aldigier, Jean-Claude
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (14)
  • [36] Biomarkers to Predict Progression in IgA Nephropathy
    Cheung, Chee Kay
    Barratt, Jonathan
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 14 (10): : 1421 - 1423
  • [37] IGA NEPHROPATHY - MORPHOLOGIC EXPRESSION AND PATHOGENESIS
    EMANCIPATOR, SN
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 23 (03) : 451 - 462
  • [38] Targeting APRIL in the Treatment of IgA Nephropathy
    Cheung, Chee Kay
    Barratt, Jonathan
    Carroll, Kevin
    Lafayette, Richard A.
    Liew, Adrian
    Suzuki, Yusuke
    Tesar, Vladimir
    Trimarchi, Hernan
    Wong, Muh Geot
    Zhang, Hong
    Perkovic, Vlado
    Rizk, Dana V.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 19 (03): : 394 - 398
  • [39] The nature of IgA molecule in IgA nephropathy
    Kar Neng LAI and Joseph C.K.LeungDepartment of Medicine
    University of Hong Kong
    Queen Mary Hospital
    Hong KongKeywords IgA nephropathy IgA molecule
    肾脏病与透析肾移植杂志, 1997, (06) : 3 - 11
  • [40] Coexisting Membranous Nephropathy and IgA Nephropathy
    Nishida, Masashi
    Kato, Ryuichi
    Hamaoka, Kenji
    FETAL AND PEDIATRIC PATHOLOGY, 2015, 34 (06) : 351 - 354